These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 19739006
21. Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil. Borges MM, Pranchevicius MC, Noronha EF, Romero GA, Carranza-Tamayo CO. Rev Soc Bras Med Trop; 2017; 50(1):67-74. PubMed ID: 28327804 [Abstract] [Full Text] [Related]
22. Mediterranean visceral leishmaniasis in pregnancy. Gradoni L, Gaeta GB, Pellizzer G, Maisto A, Scalone A. Scand J Infect Dis; 1994; 26(5):627-9. PubMed ID: 7855563 [Abstract] [Full Text] [Related]
26. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis. Oliva G, Gradoni L, Cortese L, Orsini S, Ciaramella P, Scalone A, de Luna R, Persechino A. Ann Trop Med Parasitol; 1998 Mar; 92(2):165-71. PubMed ID: 9625912 [Abstract] [Full Text] [Related]
28. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Faraut-Gambarelli F, Piarroux R, Deniau M, Giusiano B, Marty P, Michel G, Faugère B, Dumon H. Antimicrob Agents Chemother; 1997 Apr; 41(4):827-30. PubMed ID: 9087498 [Abstract] [Full Text] [Related]
32. Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate. Perez-Franco JE, Cruz-Barrera ML, Robayo ML, Lopez MC, Daza CD, Bedoya A, Mariño ML, Saavedra CH, Echeverry MC. PLoS Negl Trop Dis; 2016 May; 10(5):e0004739. PubMed ID: 27243811 [Abstract] [Full Text] [Related]
36. Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum. Buffet PA, Garin YJ, Sulahian A, Nassar N, Derouin F. Ann Trop Med Parasitol; 1996 Jun; 90(3):295-302. PubMed ID: 8758143 [Abstract] [Full Text] [Related]
38. Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid. Kato KC, Morais-Teixeira E, Reis PG, Silva-Barcellos NM, Salaün P, Campos PP, Dias Corrêa-Junior J, Rabello A, Demicheli C, Frézard F. Antimicrob Agents Chemother; 2014 Jun; 58(1):481-8. PubMed ID: 24189251 [Abstract] [Full Text] [Related]
39. Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment. Gradoni L, Maroli M, Gramiccia M, Mancianti F. Med Vet Entomol; 1987 Oct; 1(4):339-42. PubMed ID: 2979550 [Abstract] [Full Text] [Related]